Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

72 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Evaluation of a mathematical model of diabetes progression against observations in the Diabetes Prevention Program.
Hardy T, Abu-Raddad E, Porksen N, De Gaetano A. Hardy T, et al. Among authors: porksen n. Am J Physiol Endocrinol Metab. 2012 Jul 15;303(2):E200-12. doi: 10.1152/ajpendo.00421.2011. Epub 2012 May 1. Am J Physiol Endocrinol Metab. 2012. PMID: 22550065 Free article.
Basal insulin peglispro increases lipid oxidation, metabolic flexibility, thermogenesis and ketone bodies compared to insulin glargine in subjects with type 1 diabetes mellitus.
Porksen NK, Linnebjerg H, Lam ECQ, Garhyan P, Pachori A, Pratley RE, Smith SR. Porksen NK, et al. Diabetes Obes Metab. 2018 May;20(5):1193-1201. doi: 10.1111/dom.13215. Epub 2018 Feb 4. Diabetes Obes Metab. 2018. PMID: 29316143 Clinical Trial.
Mathematical models of diabetes progression.
De Gaetano A, Hardy T, Beck B, Abu-Raddad E, Palumbo P, Bue-Valleskey J, Pørksen N. De Gaetano A, et al. Among authors: porksen n. Am J Physiol Endocrinol Metab. 2008 Dec;295(6):E1462-79. doi: 10.1152/ajpendo.90444.2008. Epub 2008 Sep 9. Am J Physiol Endocrinol Metab. 2008. PMID: 18780774 Free article.
Hypoglycemia Risk Related to Double Dose Is Markedly Reduced with Basal Insulin Peglispro Versus Insulin Glargine in Patients with Type 2 Diabetes Mellitus in a Randomized Trial: IMAGINE 8.
Harris C, Forst T, Heise T, Plum-Mörschel L, Watkins E, Zhang Q, Fan L, Garhyan P, Porksen N. Harris C, et al. Among authors: porksen n. Diabetes Technol Ther. 2017 Aug;19(8):463-470. doi: 10.1089/dia.2016.0414. Diabetes Technol Ther. 2017. PMID: 28817342 Free PMC article. Clinical Trial.
Attenuated suppression of lipolysis explains the increases in triglyceride secretion and concentration associated with basal insulin peglispro relative to insulin glargine treatment in patients with type 1 diabetes.
Johansen RF, Søndergaard E, Linnebjerg H, Garhyan P, Lam ECQ, Porksen N, Jacober SJ, Nielsen S. Johansen RF, et al. Among authors: porksen n. Diabetes Obes Metab. 2018 Feb;20(2):419-426. doi: 10.1111/dom.13087. Epub 2017 Oct 10. Diabetes Obes Metab. 2018. PMID: 28817248 Clinical Trial.
Quantification of Basal Insulin Peglispro and Human Insulin in Adipose Tissue Interstitial Fluid by Open-Flow Microperfusion.
Tiffner K, Boulgaropoulos B, Höfferer C, Birngruber T, Porksen N, Linnebjerg H, Garhyan P, Lam ECQ, Knadler MP, Pieber TR, Sinner F. Tiffner K, et al. Among authors: porksen n. Diabetes Technol Ther. 2017 May;19(5):305-314. doi: 10.1089/dia.2016.0384. Epub 2017 Mar 22. Diabetes Technol Ther. 2017. PMID: 28328234 Clinical Trial.
Novel hepato-preferential basal insulin peglispro (BIL) does not differentially affect insulin sensitivity compared with insulin glargine in patients with type 1 and type 2 diabetes.
Porksen N, Linnebjerg H, Garhyan P, Lam EC, Knadler MP, Jacober SJ, Hoevelmann U, Plum-Moerschel L, Watkins E, Gastaldelli A, Heise T. Porksen N, et al. Diabetes Obes Metab. 2017 Apr;19(4):482-488. doi: 10.1111/dom.12834. Epub 2017 Feb 7. Diabetes Obes Metab. 2017. PMID: 27888561 Clinical Trial.
Hepatic and glucagon-like peptide-1-mediated reversal of diabetes by glucagon receptor antisense oligonucleotide inhibitors.
Sloop KW, Cao JX, Siesky AM, Zhang HY, Bodenmiller DM, Cox AL, Jacobs SJ, Moyers JS, Owens RA, Showalter AD, Brenner MB, Raap A, Gromada J, Berridge BR, Monteith DK, Porksen N, McKay RA, Monia BP, Bhanot S, Watts LM, Michael MD. Sloop KW, et al. Among authors: porksen n. J Clin Invest. 2004 Jun;113(11):1571-81. doi: 10.1172/JCI20911. J Clin Invest. 2004. PMID: 15173883 Free PMC article.
Engineering and characterization of the long-acting glucagon-like peptide-1 analogue LY2189265, an Fc fusion protein.
Glaesner W, Vick AM, Millican R, Ellis B, Tschang SH, Tian Y, Bokvist K, Brenner M, Koester A, Porksen N, Etgen G, Bumol T. Glaesner W, et al. Among authors: porksen n. Diabetes Metab Res Rev. 2010 May;26(4):287-96. doi: 10.1002/dmrr.1080. Diabetes Metab Res Rev. 2010. PMID: 20503261
Acute insulin response and beta-cell compensation in normal subjects treated with olanzapine or risperidone for 2 weeks.
Hardy TA, Meyers AL, Yu J, Shankar SS, Steinberg HO, Porksen NK. Hardy TA, et al. Diabetes Care. 2007 Jan;30(1):157-8. doi: 10.2337/dc06-1063. Diabetes Care. 2007. PMID: 17192353 Clinical Trial. No abstract available.
72 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback